By Receiver operating characteristic (ROC) curve analysis, we obtained sensitivity and specificity performance of plasma C2, C3, C3b, and C5 as biomarkers able to discriminate between AChR-MG patients and healthy controls (Figure 3). The gene discussed is C5; the disease is myasthenia gravis.